Cleared Traditional

K962872 - RESPIFLO

K962872 is an FDA 510(k) clearance for RESPIFLO, manufactured by Tyco Healthcare Deutschaland GmbH. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 217-day FDA review.

K962872 · Tyco Healthcare Deutschaland GmbH · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1997
Decision
217d
Days
Class 2
Risk

K962872 is an FDA 510(k) clearance for the RESPIFLO. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Tyco Healthcare Deutschaland GmbH (Neustadt A D Donau, DE). The FDA issued a Cleared decision on February 25, 1997 after a review of 217 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Tyco Healthcare Deutschaland GmbH devices

FDA 510(k) Submission Details - K962872

510(k) Number K962872 FDA.gov
FDA Decision Cleared Substantially Equivalent - Direct De Novo (SESD)
Date Received July 23, 1996
Decision Date February 25, 1997
Days to Decision 217 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 140d · This submission: 217d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 349
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K962872.
JOHN BUNN NEB-U-LITE II MEDICATION COMPRESSOR WITH DISPOSABLE NEBULIZER, MODEL #JBO-112-009
K970035 · Graham-Field, Inc. · Apr 1997
THE SWIRLER NEBULIZER
K952910 · Amici, Inc. · Mar 1997
THERA-MIST NEBULIZER MODEL-P3000
K962534 · Pegasus Research Corp. · Feb 1997
RESPIFLO/S
K962874 · Curtin & Associates International , Inc. · Feb 1997
HOLDEN-WALKER HUMIDIFIER-NEBULIZER KIT
K963917 · Holden Walker Corp. · Feb 1997
CPI MODEL 6240 50 PSI NEBULIZER COMPRESSOR
K964994 · Contemporary Products, Inc. · Feb 1997